StonvexLoading…
StonvexStonvexStonvexCore line items from VNRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.73M | $1.23M | $775.30K | $306.39K |
Operating Income | $-21.74M | $-27.02M | $-35.99M | $-31.78M |
Net Income | $-23.36M | $-26.97M | $-35.68M | $-30.60M |
EPS (Diluted) | Not available | $-0.31 | $-0.50 | Not available |
Total Assets | $6.90M | $9.40M | $27.95M | $18.30M |
Total Liabilities | $42.49M | $35.51M | $36.66M | $21.42M |
Cash & Equivalents | $1.12M | $3.26M | $20.73M | $10.87M |
Free Cash Flow OCF − CapEx | $-19.77M | $-26.17M | $-19.15M | $-16.85M |
Shares Outstanding | 125.78M | 96.10M | 81.90M | 57.87M |